Parkman Healthcare Partners LLC Legend Biotech Corp Transaction History

Parkman Healthcare Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$43.42 - $57.37 $1.92 Million - $2.54 Million	-44,324 Reduced 48.21%	47,608 $2.3 Million
Q4 2022 Feb 13, 2023	SELL	$38.8 - $55.46 $1.14 Million - $1.62 Million	-29,295 Reduced 24.17%	91,932 $4.59 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $130,473 - $195,282	3,420 Added 2.9%	121,227 $4.95 Million
Q2 2022 Aug 12, 2022	SELL	$33.54 - $55.0 $89,417 - $146,630	-2,666 Reduced 2.21%	117,807 $6.48 Million
Q1 2022 May 13, 2022	BUY	$31.02 - $48.18 $3.74 Million - $5.8 Million	120,473 New	120,473 $4.38 Million

205

74.5M

371K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.